# BONE BIOLOGICS CORP (BBLG)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/BBLG/

- Reporting holders: 3
- Reported value: $68.4K
- Shares held by institutions: 49,941 of 2,756,057 outstanding
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [CITADEL ADVISORS LLC](https://holderbook.com/funds/1423053-citadel-advisors-llc/) | $65.4K | 47,758 | 0.0% | 1 |
| [Tower Research Capital LLC (TRC)](https://holderbook.com/funds/1533421-tower-research-capital-llc-trc/) | $2.7K | 1,953 | 0.0% | 5 |
| [SBI Securities Co., Ltd.](https://holderbook.com/funds/1851815-sbi-securities-co-ltd/) | $315 | 230 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 3 | $68.4K |
| Q1 2026 | 3 | $4.9K |
| Q4 2025 | 7 | $74.1K |
| Q3 2025 | 7 | $36.7K |
| Q2 2025 | 4 | $1.8K |
| Q1 2025 | 4 | $20.8K |
| Q4 2024 | 7 | $55.8K |
| Q3 2024 | 7 | $183.4K |
| Q2 2024 | 5 | $69.7K |
| Q1 2024 | 4 | $89.1K |
| Q4 2023 | 2 | $5.6K |
| Q3 2023 | 8 | $235.1K |